About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Collaboration to develop CAR-T cell therapy for cutaneous T-cell lymphoma

Study shows enhanced drug delivery to the brain

BC Platforms receives $20M financing

Telix Pharmaceuticals sees positive results in kidney cancer imaging study 

Lipum starts chronic inflammatory disease drug study

Rallybio announces positive phase 1 results for drug treating PNH and gMG

ADVERTISEMENT

Hormone discovery could predict long term health of men

Ascentage Pharma gives positive news on chronic hepatitis B drug

First patient dose completed for bladder cancer diagnostic drug 

A new weapon against antibiotic-resistant bacteria?

Novadip Biosciences raises €40M for bone defect treatments

Beyond Biotech podcast 21: CanSinoBIO, HTID, Longevity Science Foundation

ADVERTISEMENT